Davis Polk is advising Bio-Reference Laboratories, Inc. in connection with its approximately $1.47 billion acquisition by OPKO Health, Inc. Under the terms of the agreement, holders of Bio…
Davis Polk advised the several underwriters in connection with an SEC-registered offering by Atlas Air Worldwide Holdings, Inc. of $224.5 million aggregate principal amount of its 2.25%…
Davis Polk successfully represented Dialog Semiconductors in litigation related to the earnout provisions in its 2013 acquisition of iWatt. In April 2014, Fortis Advisors—acting on behalf…
Davis Polk advised the administrative agent, in connection with $1.6 billion senior secured credit facilities for Black Knight InfoServ, LLC, comprised of an $800 million term loan A…
Davis Polk advised the joint book-running managers of a $1 billion SEC-registered offering by ArcelorMittal consisting of $500 million aggregate principal amount of 5.125% notes due 2020…
Davis Polk advised the joint book-running managers on a Rule 144A/Regulation S offering by Energizer SpinCo, Inc. of $600 million aggregate principal amount of its 5.500% senior notes due…
Davis Polk is advising J.P. Morgan Securities LLC as financial adviser to Intel Corporation in connection with its approximately $16.7 billion acquisition of Altera Corporation. The…
Davis Polk advised the joint book-running managers on the Rule 144A/Regulation S offering by Skandinaviska Enskilda Banken AB (publ) of $1 billion aggregate principal amount of 2.45% notes…
Davis Polk advised the administrative agent in connection with the refinancing of Hologic, Inc.’s existing senior secured credit facilities with a $1.5 billion term loan facility and a $1…